Perrigo Company plc Company Profile (NYSE:PRGO)

About Perrigo Company plc

Perrigo Company plc logoPerrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri. Its businesses include Consumer Healthcare, Nutritionals, Rx Pharmaceuticals, API, Life Sciences and Other Businesses. The Company offers Healthcare Products across a range of product categories primarily in the United States, the United Kingdom, Mexico, Israel and Australia. In February 2014, the Company announced that it has acquired a basket of value-brand OTC products sold in Australia and New Zealand from Aspen Global Inc.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Related Products
  • Sub-Industry: Pharmaceuticals
  • Exchange: NYSE
  • Symbol: PRGO
  • CUSIP: 71429010
Key Metrics:
  • Previous Close: $84.43
  • 50 Day Moving Average: $78.99
  • 200 Day Moving Average: $86.21
  • 52-Week Range: $71.84 - $140.65
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 11.89
  • P/E Growth: 2.88
  • Market Cap: $12.11B
  • Outstanding Shares: 143,374,000
  • Beta: 0.73
Profitability:
  • Net Margins: -26.62%
  • Return on Equity: 10.68%
  • Return on Assets: 5.39%
Debt:
  • Debt-to-Equity Ratio: 0.65%
  • Current Ratio: 1.71%
  • Quick Ratio: 1.13%
Additional Links:
Companies Related to Perrigo Company plc:

Analyst Ratings

Consensus Ratings for Perrigo Company plc (NYSE:PRGO) (?)
Ratings Breakdown: 1 Sell Rating, 14 Hold Ratings, 4 Buy Ratings
Consensus Rating:Hold (Score: 2.16)
Consensus Price Target: $99.93 (18.36% upside)

Analysts' Ratings History for Perrigo Company plc (NYSE:PRGO)
Show:
DateFirmActionRatingPrice TargetDetails
2/21/2017Canaccord GenuityInitiated CoverageBuy -> Buy$100.00View Rating Details
2/6/2017Barclays PLCLower Price TargetOverweight$110.00 -> $100.00View Rating Details
2/6/2017GuggenheimReiterated RatingBuy$125.00View Rating Details
1/30/2017Goldman Sachs Group, Inc. (The)Reiterated RatingSellView Rating Details
1/29/2017B. RileyReiterated RatingNeutral$83.00View Rating Details
1/23/2017Jefferies Group LLCLower Price TargetHold$84.00 -> $70.00View Rating Details
1/17/2017RBC Capital MarketsReiterated RatingSector Perform$92.00 -> $85.00View Rating Details
1/17/2017Royal Bank of CanadaLower Price TargetSector Perform$92.00 -> $85.00View Rating Details
11/10/2016J P Morgan Chase & CoSet Price TargetHold$95.00View Rating Details
11/11/2016Bank of America CorpUpgradeUnderperform -> NeutralView Rating Details
9/27/2016ArgusReiterated RatingHoldView Rating Details
9/13/2016Deutsche Bank AGReiterated RatingBuy$105.00View Rating Details
8/10/2016Leerink SwannSet Price TargetHold$96.00 -> $81.00View Rating Details
8/11/2016Northland SecuritiesDowngradeOutperform -> Market Perform$123.00 -> $94.00View Rating Details
6/17/2016BTIG ResearchReiterated RatingNeutralView Rating Details
6/15/2016Raymond James Financial, Inc.Reiterated RatingHoldView Rating Details
5/14/2016Morgan StanleyReiterated RatingHoldView Rating Details
4/25/2016Stifel NicolausDowngradeBuy -> HoldView Rating Details
4/25/2016Wells Fargo & CoDowngradeOutperform -> Market PerformView Rating Details
2/22/2016William BlairReiterated RatingMarket PerformView Rating Details
6/23/2015BMO Capital MarketsInitiated CoverageOutperform$246.00View Rating Details
(Data available from 2/25/2015 forward)

Earnings

Earnings History for Perrigo Company plc (NYSE:PRGO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/27/2017Q416$1.62$1.33 billionN/AView Earnings Details
11/10/2016Q316$1.58$1.65$1.28 billion$1.40 billionViewN/AView Earnings Details
8/10/2016Q216$1.98$1.93$1.43 billion$1.48 billionViewListenView Earnings Details
5/12/2016Q116$1.75$1.75$1.35 billion$1.34 billionViewListenView Earnings Details
2/18/2016Q415$1.93$1.80$1.46 billion$1.42 billionViewListenView Earnings Details
10/22/2015Q3$1.73$1.76$1.42 billion$1.34 billionViewListenView Earnings Details
8/5/2015Q2$1.96$2.18$1.52 million$1.53 millionViewN/AView Earnings Details
4/21/2015Q315$1.78$1.85$1.10 billion$1.05 billionViewN/AView Earnings Details
2/5/2015Q215$1.79$1.82$1.09 billion$1.07 billionViewN/AView Earnings Details
11/6/2014Q115$1.44$1.40$997.90 million$951.50 millionViewN/AView Earnings Details
8/14/2014Q414$1.55$1.74$1.09 billion$1.14 billionViewN/AView Earnings Details
5/7/2014Q314$1.51$1.31$1.07 billion$1,000.00 millionViewN/AView Earnings Details
2/6/2014Q214$1.59$1.87$996.68 million$979.00 millionViewN/AView Earnings Details
10/31/2013Q114$1.40$1.52$900.10 million$933.00 millionViewN/AView Earnings Details
8/15/2013Q4 2013$1.56$1.57$999.08 million$967.20 millionViewN/AView Earnings Details
5/7/2013Q3 2013$1.44$1.42$935.44 million$919.83 millionViewN/AView Earnings Details
2/1/2013Q2 2013$1.31$1.36$881.84 million$882.96 millionViewN/AView Earnings Details
11/7/2012Q113$1.24$1.27$825.83 million$769.80 millionViewN/AView Earnings Details
8/16/2012$1.27$1.28ViewN/AView Earnings Details
5/8/2012$1.22$1.41ViewN/AView Earnings Details
2/7/2012$1.15$1.20ViewN/AView Earnings Details
10/27/2011$1.06$1.10ViewN/AView Earnings Details
8/16/2011$0.97$1.02ViewN/AView Earnings Details
5/3/2011$0.97$1.07ViewN/AView Earnings Details
2/1/2011$0.95$1.05ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Perrigo Company plc (NYSE:PRGO)
Current Year EPS Consensus Estimate: $6.95 EPS
Next Year EPS Consensus Estimate: $7.10 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$2.27$2.27$2.27
Q2 20161$2.47$2.47$2.47
Q3 20161$2.25$2.25$2.25
Q4 20161$2.42$2.42$2.42
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Perrigo Company plc (NYSE:PRGO)
Annual Dividend:$0.58
Dividend Yield:0.69%
Dividend Growth:17.20% (3 Year Average)
Payout Ratio:-5.53% (Based on Trailing 12 Months of Earnings)
8.35% (Based on Current Year Consensus EPS Estimate)
8.17% (Based on Next Year Consensus EPS Estimate)
Track Record:14 Years of Consecutive Dividend Growth

Dividend History for Perrigo Company plc (NYSE:PRGO)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/21/2017quarterly$0.160.76%3/1/20173/3/20173/21/2017
11/8/2016quarterly$0.150.69%11/22/201611/25/201612/13/2016
8/2/2016quarterly$0.150.62%8/24/20168/26/20169/13/2016
4/26/2016$0.155/25/20165/27/20166/14/2016
4/26/2016quarterly$0.155/25/20165/27/20166/14/2016
2/16/2016quarterly$0.152/24/20162/26/20163/15/2016
11/4/2015quarterly$0.1311/24/201511/27/201512/15/2015
8/12/2015quarterly$0.138/26/20158/28/20159/15/2015
4/29/2015quarterly$0.130.27%5/27/20155/29/20156/16/2015
1/27/2015quarterly$0.132/25/20152/27/20153/17/2015
11/3/2014quarterly$0.110.26%11/27/201411/28/201412/16/2014
8/13/2014quarterly$0.110.28%8/27/20148/29/20149/16/2014
4/28/2014quarterly$0.110.29%5/28/20145/30/20146/17/2014
1/29/2014quarterly$0.110.27%2/26/20142/28/20143/18/2014
11/6/2013quarterly$0.090.25%11/26/201311/29/201312/17/2013
8/14/2013quarterly$0.090.29%8/28/20138/30/20139/17/2013
5/2/2013quarterly$0.090.3%5/29/20135/31/20136/18/2013
1/31/2013quarterly$0.090.34%2/27/20133/1/20133/19/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Perrigo Company plc (NYSE:PRGO)
Insider Ownership Percentage: 4.47%
Institutional Ownership Percentage: 69.65%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/25/2016Judy L BrownEVPSell2,097$89.44$187,555.68View SEC Filing  
11/21/2016Geoffrey M ParkerDirectorBuy2,500$88.75$221,875.00View SEC Filing  
10/24/2016Judy L BrownEVPSell2,092$90.42$189,158.64View SEC Filing  
9/26/2016Judy L BrownCFOSell2,096$96.76$202,808.96View SEC Filing  
9/26/2016Thomas FarringtonEVPSell1,110$96.76$107,403.60View SEC Filing  
9/9/2016Gary K Kunkle JrDirectorSell5,814$89.95$522,969.30View SEC Filing  
9/8/2016Herman Morris JrDirectorSell1,073$90.96$97,600.08View SEC Filing  
8/26/2016Judy L BrownEVPSell2,095$88.28$184,946.60View SEC Filing  
4/13/2016Judy L BrownCFOSell2,776$126.22$350,386.72View SEC Filing  
3/18/2016Michael J JandernoaDirectorSell761$128.29$97,628.69View SEC Filing  
3/2/2016Sharon KochanEVPSell1,490$125.28$186,667.20View SEC Filing  
2/24/2016Judy L BrownCFOSell2,776$123.73$343,474.48View SEC Filing  
1/6/2016Judy L. BrownCFOSell27,737$142.41$3,950,026.17View SEC Filing  
12/28/2015Joseph C. PapaChairmanSell10,183$147.07$1,497,613.81View SEC Filing  
8/25/2015John T. HendricksonEVPSell1,737$181.37$315,039.69View SEC Filing  
8/25/2015Todd W. KingmaVPSell1,715$181.37$311,049.55View SEC Filing  
8/24/2015John T. HendricksonEVPSell4,468$177.68$793,874.24View SEC Filing  
4/29/2015Todd W KingmaVPSell1,700$190.27$323,459.00View SEC Filing  
4/14/2015John T HendricksonEVPSell8,800$200.27$1,762,376.00View SEC Filing  
4/13/2015Todd W KingmaVPSell1,300$198.44$257,972.00View SEC Filing  
3/13/2015Jatin ShahSVPSell2,000$165.50$331,000.00View SEC Filing  
10/1/2014Judy L BrownCFOSell3,515$150.72$529,780.80View SEC Filing  
9/3/2014Sharon KochanEVPSell1,116$150.00$167,400.00View SEC Filing  
9/3/2014Todd W KingmaVPSell2,250$149.65$336,712.50View SEC Filing  
9/2/2014Judy L BrownCFOSell3,515$149.32$524,859.80View SEC Filing  
9/2/2014Thomas FarringtonVPSell1,741$150.36$261,776.76View SEC Filing  
8/27/2014Michael Robert StewartVPSell4,519$148.78$672,336.82View SEC Filing  
8/26/2014Jeffrey NeedhamVPSell10,205$148.54$1,515,850.70View SEC Filing  
8/26/2014Judy L BrownCFOSell4,827$148.87$718,595.49View SEC Filing  
8/25/2014John T HendricksonEVPSell2,533$148.44$375,998.52View SEC Filing  
5/15/2014Ran GottfriedDirectorSell1,000$131.25$131,250.00View SEC Filing  
3/24/2014Joseph PapaChairmanSell10,000$157.72$1,577,200.00View SEC Filing  
1/16/2014Joseph PapaChairmanSell5,000$157.59$787,950.00View SEC Filing  
12/12/2013Gary CohenDirectorSell4,632$152.52$706,472.64View SEC Filing  
12/12/2013Joseph PapaChairmanSell15,000$150.12$2,251,800.00View SEC Filing  
12/9/2013Michael JandernoaDirectorSell128,620$155.30$19,974,686.00View SEC Filing  
11/25/2013Louis YuVPSell2,292$155.51$356,428.92View SEC Filing  
11/21/2013Judy BrownCFOSell9,988$154.74$1,545,543.12View SEC Filing  
11/20/2013John HendricksonEVPSell8,400$152.80$1,283,520.00View SEC Filing  
11/4/2013Ran GottfriedDirectorSell2,275$143.36$326,144.00View SEC Filing  
9/24/2013Joseph PapaChairmanSell15,000$124.60$1,869,000.00View SEC Filing  
9/18/2013John HendricksonEVPSell2,161$125.00$270,125.00View SEC Filing  
9/11/2013Michael Robert StewartVPSell5,063$123.37$624,622.31View SEC Filing  
9/9/2013Louis YuVPSell1,852$124.11$229,851.72View SEC Filing  
9/6/2013John T HendricksonEVPSell1,000$123.46$123,460.00View SEC Filing  
9/4/2013John T HendricksonEVPSell2,000$123.92$247,840.00View SEC Filing  
9/3/2013Judy BrownCFOSell2,500$122.07$305,175.00View SEC Filing  
8/30/2013Jeffrey NeedhamVPSell6,585$120.47$793,294.95View SEC Filing  
8/29/2013Sharon KochanVPSell3,467$120.98$419,437.66View SEC Filing  
8/27/2013Joseph PapaChairmanSell15,000$117.64$1,764,600.00View SEC Filing  
8/26/2013John HendricksonEVPSell2,099$119.15$250,095.85View SEC Filing  
8/26/2013Judy BrownCFOSell3,424$119.28$408,414.72View SEC Filing  
8/20/2013John HendricksonEVPSell1,676$118.56$198,706.56View SEC Filing  
8/20/2013Judy BrownCFOSell2,804$118.58$332,498.32View SEC Filing  
8/20/2013Thomas FarringtonVPSell1,658$119.86$198,727.88View SEC Filing  
8/16/2013Todd KingmaVPSell1,250$120.00$150,000.00View SEC Filing  
7/19/2013Todd W KingmaVPSell1,250$129.37$161,712.50View SEC Filing  
7/11/2013Joseph C PapaChairmanSell10,000$128.54$1,285,400.00View SEC Filing  
7/9/2013John T HendricksonEVPSell2,161$125.00$270,125.00View SEC Filing  
6/14/2013Joseph C PapaChairmanSell10,000$118.39$1,183,900.00View SEC Filing  
6/14/2013Todd W KingmaVPSell1,250$118.00$147,500.00View SEC Filing  
6/4/2013Judy L BrownCFOSell2,500$116.38$290,950.00View SEC Filing  
5/14/2013Sharon KochanVPSell2,647$119.64$316,687.08View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Perrigo Company plc (NYSE:PRGO)
DateHeadline
News IconPerrigo Co. (PRGO) Stake Boosted by the Nationwide Fund Advisors - Petro Global News 24 (NYSE:PRGO)
petroglobalnews24.com - February 25 at 6:55 PM
News IconCanaccord Genuity Initiates Coverage On Perrigo Company plc Ordinary Shares to Buy (NYSE:PRGO)
prensariotiretail.com - February 24 at 12:27 AM
News IconPerrigo Company Plc (NYSE:PRGO) Receives Buy Rating From Canaccord Genuity Analysts (NYSE:PRGO)
oakridgeobserver.com - February 24 at 12:27 AM
News IconPerrigo Company plc (PRGO) Raises Dividend to $0.16 Per Share (NYSE:PRGO)
eleganthomesinla.com - February 24 at 12:27 AM
News IconTrading Levels in Focus: Perrigo Company PLC (PRGO) - Searcy News (NYSE:PRGO)
searcysentinel.com - February 23 at 7:27 PM
News IconStock Check for Perrigo Company PLC (PRGO) - Baxter Review (NYSE:PRGO)
baxternewsreview.com - February 23 at 12:28 AM
News IconPerrigo Company plc Ordinary Shares (PRGO) is Initiated by Canaccord Genuity to “Buy” - Highland Mirror (NYSE:PRGO)
www.highlandmirror.com - February 23 at 12:28 AM
prnewswire.com logoPerrigo Company plc Announces Quarterly Dividend - PR Newswire (press release) (NYSE:PRGO)
www.prnewswire.com - February 23 at 12:28 AM
finance.yahoo.com logoCoverage initiated on Perrigo by Canaccord Genuity (NYSE:PRGO)
finance.yahoo.com - February 22 at 7:27 PM
finance.yahoo.com logoIsraeli supermarket chain Shufersal Q4 profit up (NYSE:PRGO)
finance.yahoo.com - February 22 at 9:22 AM
us.rd.yahoo.com logoPerrigo Company plc Announces Quarterly Dividend (NYSE:PRGO)
us.rd.yahoo.com - February 21 at 5:34 PM
News IconPerrigo Company plc Ordinary Shares (NYSE:PRGO) Gets FDA Approval For Its Hydrocodone Bitartrate and Homatropine Methybromide Oral Solution (NYSE:PRGO)
stockmarketdaily.co - February 17 at 8:08 PM
us.rd.yahoo.com logoPerrigo Announces FDA Final Approval For Hydrocodone Bitartrate And Homatropine Methylbromide Oral Solution (NYSE:PRGO)
us.rd.yahoo.com - February 17 at 8:08 PM
us.rd.yahoo.com logo8:44 am Perrigo receives FDA approval for hydrocodone bitartrate and homatropine methylbromide oral solution (syrup), 5 mg/1.5 mg per 5 mL (NYSE:PRGO)
us.rd.yahoo.com - February 17 at 8:08 PM
finance.yahoo.com logoPerrigo To Release Fourth Quarter And Calendar Year 2016 Results On February 27, 2017 (NYSE:PRGO)
finance.yahoo.com - February 14 at 11:47 PM
investopedia.com logoStarboard Value's Jeff Smith Wins Five Perrigo Board Seats (PRGO) (NYSE:PRGO)
www.investopedia.com - February 14 at 12:05 AM
investopedia.com logoStarboard Value's Jeff Smith Wins Five Perrigo Board Seats (NYSE:PRGO)
www.investopedia.com - February 14 at 12:05 AM
News IconStock ABR Of Perrigo Company (NYSE:PRGO) At 2.57 - Stock Observer (NYSE:PRGO)
www.thestockobserver.com - February 12 at 8:32 AM
barrons.com logo[$$] Deckers Outdoor Attracts Activist Investment Firm Marcato (NYSE:PRGO)
www.barrons.com - February 11 at 2:24 AM
thestreet.com logoWith Starboard's Smith at Perrigo, Expect M&A, Stock Buybacks (NYSE:PRGO)
www.thestreet.com - February 8 at 8:59 PM
News IconGuess Who Picked Up Perrigo Co Plc. (NYSE:PRGO) Shares - Small Cap Exclusive (press release) (NYSE:PRGO)
smallcapexclusive.com - February 8 at 2:54 AM
rttnews.com logoPerrigo Files New Drug Application For Generic Version Of Onexton Gel (NYSE:PRGO)
www.rttnews.com - February 7 at 9:53 PM
News IconStarboard Gets Seats at Perrigo -- Market Talk (NYSE:PRGO)
ih.advfn.com - February 7 at 9:53 PM
seekingalpha.com logoPerrigo shakes up board; shares ahead 2% premarket (NYSE:PRGO)
seekingalpha.com - February 7 at 9:53 PM
prnewswire.com logoPerrigo Announces Agreement With Starboard (NYSE:PRGO)
www.prnewswire.com - February 7 at 9:53 PM
streetinsider.com logoPerrigo (PRGO) Reaches Agreement With Starboard; 3 Added to Board, to Recommend 2 Others (NYSE:PRGO)
www.streetinsider.com - February 7 at 9:53 PM
News IconPerrigo Company plc Ordinary Shares (NYSE:PRGO) Shares Trade Higher After Striking A Deal With Activist Investor (NYSE:PRGO)
stockmarketdaily.co - February 7 at 9:53 PM
us.rd.yahoo.com logoPerrigo adds Starboard CEO to its board (NYSE:PRGO)
us.rd.yahoo.com - February 7 at 9:53 PM
sg.finance.yahoo.com logoInvestor Starboard takes several seats on Perrigo board (NYSE:PRGO)
us.rd.yahoo.com - February 7 at 9:53 PM
wsj.com logo[$$] Starboard Reaches Deal to Shake Up Perrigo Board (NYSE:PRGO)
us.rd.yahoo.com - February 7 at 9:53 PM
News IconPerrigo Company (NYSE:PRGO) Projected EPS At $1.62 - Stock Observer (NYSE:PRGO)
www.thestockobserver.com - February 7 at 8:44 AM
streetinsider.com logoPerrigo (PRGO) Confirms Patent Challenge for Valeant's (VRX) Onexton Gel - StreetInsider.com (NYSE:PRGO)
www.streetinsider.com - February 7 at 8:44 AM
streetinsider.com logoPerrigo (PRGO) Reaches Agreement With Starboard; 3 Added to Board, to Recommend 2 Others - StreetInsider.com (NYSE:PRGO)
www.streetinsider.com - February 7 at 8:44 AM
marketwatch.com logoPerrigo says it has filed for FDA approval for a generic version of Valeant's acne gel (NYSE:PRGO)
www.marketwatch.com - February 7 at 8:44 AM
News IconStock ABR Of Perrigo Company (NYSE:PRGO) At 2.57 | Stock ... - Stock Observer (NYSE:PRGO)
www.thestockobserver.com - February 5 at 7:09 PM
News IconPerrigo Company (NYSE:PRGO) Stock Price Target Given At ... - Transcript Daily (NYSE:PRGO)
transcriptdaily.com - February 5 at 7:09 PM
News IconLeading stocks in today’s market: Perrigo Company plc (NYSE:PRGO) (NYSE:PRGO)
twincountynews.com - February 4 at 7:24 PM
News IconPerrigo Company plc (NYSE:PRGO) from Drug Related Products – Todays Top Gains (NYSE:PRGO)
twincountynews.com - February 3 at 8:11 PM
benzinga.com logoNajarian Brothers See Unusual Options Activity In Perrigo And Restoration Hardware - Benzinga (NYSE:PRGO)
www.benzinga.com - February 2 at 8:57 PM
finance.yahoo.com logoUnusual activity: Bulls pile into PRGO & RH (NYSE:PRGO)
finance.yahoo.com - February 2 at 8:57 PM
News IconPerrigo Company (NYSE:PRGO) Price Target Expected At $94.928 - Transcript Daily (NYSE:PRGO)
transcriptdaily.com - January 31 at 9:04 PM
News IconMA Levels in Review for Perrigo Co. (PRGO) - Springdale Times (NYSE:PRGO)
springdaletimes.com - January 30 at 8:17 AM
News IconShares of Perrigo Company (PRGO) Sees Large Outflow of Money - Highland Mirror (NYSE:PRGO)
www.highlandmirror.com - January 30 at 8:17 AM
finance.yahoo.com logoJerome Dodson Comments on Perrigo (NYSE:PRGO)
finance.yahoo.com - January 26 at 1:57 AM
News IconJefferies & Co reiterated Perrigo Company Plc (NYSE:PRGO) as 'Hold' With 70 PT - UK Market News (NYSE:PRGO)
www.ukmarketnews.co.uk - January 25 at 1:09 AM
schaeffersresearch.com logoAnalyst Downgrades: Perrigo Company plc, QUALCOMM, Inc., and Verizon Communications Inc. - Schaeffers Research (blog) (NYSE:PRGO)
www.schaeffersresearch.com - January 25 at 1:09 AM
streetinsider.com logoPerrigo (PRGO) Reports FDA Approval of First-To-File AB Rated Generic Version of Topicort Spray, 0.25% - StreetInsider.com (NYSE:PRGO)
www.streetinsider.com - January 25 at 1:09 AM
streetinsider.com logoPerrigo (PRGO) Reports FDA Approval of First-To-File AB Rated Generic Version of Topicort Spray, 0.25% (NYSE:PRGO)
www.streetinsider.com - January 24 at 8:08 PM
finance.yahoo.com logoPerrigo Announces FDA Approval Of Its First-To-File AB Rated Generic Version Of Topicort® Spray, 0.25% (NYSE:PRGO)
finance.yahoo.com - January 24 at 8:08 PM
finance.yahoo.com logo8:42 am Perrigo receives FDA approval for its first-to-file Abbreviated New Drug Application referencing Taro Pharmaceuticals USA's (TARO (NYSE:PRGO)
finance.yahoo.com - January 24 at 8:08 PM

Social

What is Perrigo Company plc's stock symbol?

Perrigo Company plc trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO."

How often does Perrigo Company plc pay dividends? What is the dividend yield for Perrigo Company plc?

Perrigo Company plc announced a quarterly dividend on Tuesday, February 21st. Shareholders of record on Friday, March 3rd will be paid a dividend of $0.16 per share on Tuesday, March 21st. This represents a $0.64 annualized dividend and a yield of 0.76%. The ex-dividend date is Wednesday, March 1st. This is a boost from Perrigo Company plc's previous quarterly dividend of $0.15.

Where is Perrigo Company plc's stock going? Where will Perrigo Company plc's stock price be in 2017?

19 brokerages have issued twelve-month price targets for Perrigo Company plc's stock. Their forecasts range from $70.00 to $160.00. On average, they anticipate Perrigo Company plc's share price to reach $99.93 in the next twelve months.

When will Perrigo Company plc announce their earnings?

Perrigo Company plc is scheduled to release their next quarterly earnings announcement on Monday, February, 27th 2017.

What are analysts saying about Perrigo Company plc stock?

Here are some recent quotes from research analysts about Perrigo Company plc stock:

  • Jefferies Group LLC analysts commented, "We had a follow up discussion with PRGO mgt Friday post our in person meeting Jan 11 to clarify financial metrics. We are lowering our FY17 and FY18 rev and EPS ests by $394M & $0.65 and $386M & $0.64 respectively. We have reconfigured the co's reporting segments but have not made any assumptions regarding the potential divestitures of the generics business or Tysabri royalties in our model. Rolling forward our valuation metrics, our new PT is $70 (vs $84)." (1/23/2017)
  • According to Zacks Investment Research, "Perrigo has a presence in the OTC market and sells generic and specialty pharma drugs as well. We are positive on the company’s focus on acquisition-driven growth. The Mar 2015 Omega Pharma acquisition has expanded product offerings in the European OTC market. Going forward, we could see more of such merger & acquisition activities at the company. Moreover, the company’s restructuring plans to boost shareholder value look encouraging. However, the company had provided a dull outlook for both 2016 earnings and revenues, which is concerning. The cut in the earnings guidance reflects softness in pricing in the Rx segment due to industry and competitive pressures. The company expects this softness to continue impacting its fundamentals through 2016. The reduction was also due to a weaker performance expected within the BCH segment over the next three quarters as well as low expectations for consolidated new product launches." (7/25/2016)

Who owns Perrigo Company plc stock?

Perrigo Company plc's stock is owned by a number of of institutional and retail investors. Top institutional investors include State Street Corp (4.27%), Franklin Resources Inc. (2.34%), Aberdeen Asset Management PLC UK (1.28%), Ruane Cunniff & Goldfarb Inc. (0.92%), FMR LLC (0.76%) and Renaissance Technologies LLC (0.44%). Company insiders that own Perrigo Company plc stock include Gary K Kunkle Jr, Geoffrey M Parker, Herman Morris Jr, Jatin Shah, John T Hendrickson, Joseph C Papa, Judy L Brown, Michael J Jandernoa, Sharon Kochan, Thomas Farrington and Todd W Kingma.

Who sold Perrigo Company plc stock? Who is selling Perrigo Company plc stock?

Perrigo Company plc's stock was sold by a variety of institutional investors in the last quarter, including Aberdeen Asset Management PLC UK, Menora Mivtachim Holdings LTD., Baird Financial Group Inc., Ruane Cunniff & Goldfarb Inc., Putnam Investments LLC, Silvercrest Asset Management Group LLC, Public Sector Pension Investment Board and Franklin Resources Inc.. Company insiders that have sold Perrigo Company plc stock in the last year include Gary K Kunkle Jr, Herman Morris Jr, Judy L Brown, Michael J Jandernoa, Sharon Kochan and Thomas Farrington.

Who bought Perrigo Company plc stock? Who is buying Perrigo Company plc stock?

Perrigo Company plc's stock was purchased by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, State Street Corp, FMR LLC, Credit Agricole S A, Allianz Asset Management AG, Marshall Wace LLP, Denver Investment Advisors LLC and Guggenheim Capital LLC.

How do I buy Perrigo Company plc stock?

Shares of Perrigo Company plc can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Perrigo Company plc stock cost?

One share of Perrigo Company plc stock can currently be purchased for approximately $84.43.

Perrigo Company plc (NYSE:PRGO) Chart for Saturday, February, 25, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Perrigo Company plc (NYSE:PRGO)

Earnings History Chart

Earnings by Quarter for Perrigo Company plc (NYSE:PRGO)

Dividend History Chart

Dividend Payments by Quarter for Perrigo Company plc (NYSE:PRGO)

Last Updated on 2/25/2017 by MarketBeat.com Staff